Korean J Med.
2012 Sep;83(3):305-308.
Adjuvant Chemotherapy in Non-Small Cell Lung Cancer
- Affiliations
-
- 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. kimdw@snu.ac.kr
Abstract
- Complete surgical resection is a potentially curable treatment for localized non-small cell lung cancer. However, unfortunately, a significant proportion of patients experience recurrence after curative intent operation. To reduce the rate of recurrence after surgery, adjuvant chemotherapy has been studied in a series of randomized trials. The aim of the present review is to summarize the expected survival benefit of adjuvant chemotherapy and to define the adequate target population of adjuvant treatment based on the results from large randomized trials.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Adjuvant Chemotherapy for Completely Resected Non-Small Cell Lung Cancer
- Cytotoxic Chemotherapy for Non-small Cell Lung Cancer
- Update on Adjuvant Treatment in Resectable Non-Small Cell Lung Cancer and Potential Biomarkers Predicting Postoperative Relapse
- Adjuvant Chemotherapy after Surgical Resection for Small-Cell Carcinoma of Lung
- Adjuvant treatment for resectable non-small cell lung cancer
